The exact mechanisms of methotrexate-induced renal toxicity have not yet been determined. However, several hypotheses have been put forward, including oxidative stress. The aim of this study was to investigate the role of caffeic acid phenethyl ester (Caffeic Ester), a novel antioxidant, on methotrexate-induced renal oxidative stress in rats. Nineteen adult male rats were equally divided into three experimental groups as follows: control group, methotrexate-treated group, and methotrexate-/Caffeic Ester-treated group. A single dose of methotrexate (20 mg/kg) was administered intraperitoneally (ip). Caffeic Ester (10 mmol/kg) was administered ip, once daily for seven days. Malondialdehyde (MDA) levels (an index of lipid peroxidation) were used as a marker of oxidative stress-induced renal injury. Similarly, the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px) were determined to evaluate the changes of antioxidant status in renal tissue. Methotrexate administration to control rats increased MDA levels (PB < 0.0001), but decreased SOD, CAT and GSH-Px activities in renal tissue (PB < 0.0001). Caffeic Ester-/methotrexate treatment caused a significant decrease in MDA levels (PB < 0.001), and caused an increase in SOD, CAT and GSH-Px activities when compared with methotrexate treatment alone (PB < 0.001, < 0.05, < 0.0001, respectively). In conclusion, methotrexate leads to a reduction in antioxidant enzymatic defense capacity and causes lipid peroxidation in renal tissue. Similarly, Caffeic Ester exhibits protective effects on methotrexate-induced renal oxidative impairment in rats.
Abelson, H. T., Fosburg, M. T. and Beardsley, G. P.et al.1983: Methotrexate induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucov-orin and thymidine. Journal of Clinical Oncology1, 208-216.
2.
Aebi, Y.1984: Catalase in vitro. Methods in Enzymology105, 121-126.
3.
Babiak, R. M., Campello, A. P., Carnieri, E. G. and Oliveira, M. B.1989: Methotrexate: pentose cycle and oxidative stress. Cell Biochemistry and Function16, 283-293.
4.
Balogun, E., Hoque, M. and Gong, P.et al.2003: Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochemical Society371, 887-895.
5.
Caetano, N. N., Campello, A. P. and Carnieri, E. G. S.et al.1997: Effects of methotrexate (methotrexate) on NAD(P)- dehydrogenases of HeLa cells: malic enzymes, 2-oxoglutarate and isocitrate dehydrogenases. Cell Biochemistry and Function15, 259-264.
6.
Capel, I. D., Leach, D. and Dorrell, H. M.1983: Vitamin E retards the lipoperoxidation resulting from anticancer drug administration. Anticancer Research3, 59-62.
7.
Chen, Y. J., Shiao, M. S. and Wang, S. Y.2001: The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anticancer Drugs12, 143-149.
8.
Deray, G., Khayat, D. and Cacoub, P.et al.1989: The effects of diltiazem on methotrexate-induced nephrotoxicity. European Journal of Clinical Pharmacology37, 337-340.
9.
Draper, H. H. and Hadley, M.1990: Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology186, 421-431.
10.
Fesen, M. R., Pommier, Y. and Leteurtre, E.et al.1994: Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (Caffeic Ester) and related compounds. Biochemical Pharmacology48, 595-608.
11.
Fuskevag, O. M., Kristiansen, C. and Olsen, R.et al.2000: Microvascular perturbations in rats receiving the maximum tolerated dose of methotrexate or its major metabolite 7-hydroxymethotrexate. Ultrastructural Pathology24, 325-332.
12.
Gurer, H. and Ercal, N.2000: Can antioxidants be beneficial in the treatment of lead poisoning?Free Radical Biology and Medicine29, 927-945.
13.
Heenen, M., Laporte, M. and De Graef, C.1988: Methotrexate induces apoptotic cell death in human keratinocytes. Archives for Dermatological Research290, 240-245.
14.
Hempel, L., Misselwitz, J. and Fleck, C.et al.2003: Influence of high-dose methotrexate therapy (HD-methotrexate) on glomerular and tubular kidney function. Medical and Pediatric Oncology40, 348-354.
15.
Jahovic, N., Cevik, H. and Sehirli, A. O.et al.2003: Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. Journal of Pineal Research34, 282-287.
16.
Jolivet, J., Cowan, K. H. and Curt, G. A.et al.1983: The pharmacology and clinical use of methotrexate. New England Journal of Medicine309, 1094-1104.
17.
Kroger, H., Hauschild, A. and Ohde, M.et al.1999: Nicotinamide and methionine reduce the liver toxic effect of methotrexate. General Pharmacology33, 203-206.
18.
Lee, S. M., Koh, H. J. and Park, D. C.et al.2002: Cytosolic NADP (-/)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radical Biology and Medicine32, 1185-1196.
19.
Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J.1951: Protein measurement with the folin phenol reagent. Journal of Clinical Chemistry193, 265-269.
20.
Michaluart, P., Masferrer, J. L. and Carothers, A. M.et al.1999: Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in rat model of inflammation. Cancer Research59, 2347-2352.
21.
Miyazono, Y., Gao, F. and Horie, T.2004: Oxidative stress contributes to methotrexate-induced small intestinal toxi-city in rats. Scandinavian Journal of Gastroenterology39, 1119-1127.
22.
Oktem, F., Arslan, M. K. and Dündar, B.et al.2004: Renal effects and erythrocyte oxidative stress in long term lead-exposed adolescent workers in auto repair workshops. Archives of Toxicology78, 681-687.
23.
Oktem, F., Ozguner, F. and Sulak, O.et al.2005: Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Molecular and Cellular Biochemistry277, 109-115.
24.
Ozen, S., Akyol, O. and Iraz, M.et al.2004: Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. Journal of Applied Toxicology24, 27-35.
25.
Ozguner, F., Oktem, F. and Armagan, A.et al.2005a: Comparative analysis of the protective effects of melatonin and caffeic acid phenethyl ester (CAPE) on 900 MHz emitted mobile phone-induced renal impairment in rat. Molecular and Cellular Biochemistry276, 31-37.
26.
Ozguner, F., Armagan, A. and Koyu, A.et al.2005b: A novel antioxidant agent caffeic acid phenethyl ester (CAPE) prevents shock wave-induced renal tubular oxidative stress. Urological Research33, 239-243.
27.
Ozyurt, H., Irmak, M. K., Akyol, O. and Sogut, S.2001: Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischaemiareperfusion injury. Cell Biochemistry and Function19, 259-263.
28.
Paglia, D. E. and Valentine, W. N.1967: Studies on the quantitative and qualitative characterization of erythrocyte GSH peroxidase. The Journal of Laboratory Clinical Medicine70, 158-169.
29.
Parlakpinar, H., Tasdemir, S. and Polat, A.et al.2005: Protective role of caffeic acid phenethyl ester (CAPE) on gentamicin-induced acute renal toxicity in rats. Toxicology207, 169-177.
30.
Rao, C., Desai, D. and Kaul, B.et al.1992: Effect of caffeic acid esters on carcinogen-induced mutagenicity and human colon adenocarcinoma cell growth. Chemico-Biological Interactions84, 277-290.
31.
Schornagel, J. H. and Mcvie, J. G.1983: The clinical pharmacology of methotrexate. Cancer Treatment Reviews10, 53-57.
32.
Smeland, E., Fuskevag, O. M. and Nymann, K.et al.1996: High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model. Cancer Chemotherapy and Pharmacology37, 415-422.
33.
Subramaniam, S. and Shyamala Devi, C. S.1995: Vitamin E protects intestinal basolateral membrane from CMF-induced damages in rat. Indian Journal of Physiology and Pharmacology39, 263-266.
34.
Sud’ina, G. F., Mirzoeva, O. K. and Pushkareva, G. A.et al.1993: Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Letters329, 21-24.
35.
Sun, Y., Oberley, L. W. and Li, Y.1988: A simple method for clinical assay of superoxide dismutase. Clinical Chemistry34, 497-500.
36.
van Ede, A. E., Laan, R. F. J. M. and De Abreu, R. A.et al.2002: Purine enzymes in patients with rheumatoid arthritis treated with methotrexate. Annals of the Rheumatic Diseases61, 1060-1064.
37.
Widemann, B. C., Balis, F. M. and Kempf-Bielack, B.et al.2004: High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma: incidence, treatment, and outcome. Cancer100, 2222-2232.
38.
Yamamoto, N. S., Lopes, L. C. V., Campello, A. P. and Kluppel, M. L. W.1989: Methotrexate: studies on cellular metabolism. II. Effects on mitochondrial metabolism and ion transport. Cell Biochemistry and Function7, 129-134.
39.
Yilmaz, H. R., Uz, E. and Yucel, N.et al.2004: Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. Journal of Biochemical and Molecular Toxicology18, 234-238.
